Northern Trust
SGMT icon

Northern Trust’s Sagimet Biosciences SGMT Stock Holding History

Northern Trust’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$290K Hold
55,511
– – ﹤0.01% 3811
2025
Q4 		$329K Buy
55,511
+3,214
+6% +$23.1K ﹤0.01% 3800
2025
Q3 		$359K Hold
52,297
– – ﹤0.01% 3769
2025
Q2 		$399K Hold
52,297
– – ﹤0.01% 3722
2025
Q1 		$170K Buy
52,297
+11,439
+28% +$48K ﹤0.01% 3987
2024
Q4 		$184K Hold
40,858
– – ﹤0.01% 4016
2024
Q3 		$113K Sell
40,858
-109,120
-73% -$336K ﹤0.01% 4020
2024
Q2 		$513K Sell
149,978
-18,267
-11% -$83.8K ﹤0.01% 3500
2024
Q1 		$912K Buy
168,245
+121,427
+259% +$872K ﹤0.01% 3351
2023
Q4 		$254K Buy
46,818
+4,892
+12% +$23.1K ﹤0.01% 3801
2023
Q3 		$369K Buy
+41,926
New +$558K ﹤0.01% 3597

Other funds holding SGMT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust's SGMT Position: Q1 2026 in Review

Northern Trust held its Sagimet Biosciences (SGMT) position steady in Q1 2026 at 55,511 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #3811.

Northern Trust first reported a position in SGMT in Q3 2023 and has held it in 11 quarters since. The position peaked at $912K in Q1 2024. 88 funds tracked by Wall St. Rank hold SGMT as of Q1 2026.

  • Northern Trust held 55,511 shares of Sagimet Biosciences worth $290K as of Q1 2026.
  • Northern Trust left its Sagimet Biosciences share count unchanged in Q1 2026.
  • Sagimet Biosciences made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3811 holding.
  • Northern Trust first reported a position in Sagimet Biosciences in Q3 2023 and has held it in 11 quarters since.
  • Northern Trust's Sagimet Biosciences position peaked at $912K in Q1 2024.
  • 88 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.